Molecular and Therapeutic Insights of Rapamycin: a Multi-faceted Drug from Streptomyces Hygroscopicus

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2023 Jan 25

PMID 36696023

Authors

Sanjeev K Ganesh

C Subathra Devi

Affiliations

Soon will be listed here.

Abstract

The advancement in pharmaceutical research has led to the discovery and development of new combinatorial life-saving drugs. Rapamycin is a macrolide compound produced from Streptomyces hygroscopicus. Rapamycin and its derivatives are one of the promising sources of drug with broad spectrum applications in the medical field. In recent times, rapamycin has gained significant attention as of its activity against cytokine storm in COVID-19 patients. Rapamycin and its derivatives have more potency when compared to other prevailing drugs. Initially, it has been used exclusively as an anti-fungal drug. Currently rapamycin has been widely used as an immunosuppressant. Rapamycin is a multifaceted drug; it has anti-cancer, anti-viral and anti-aging potentials. Rapamycin has its specific action on mTOR signaling pathway. mTOR has been identified as a key regulator of different pathways. There will be an increased demand for rapamycin, because it has lesser adverse effects when compared to steroids. Currently researchers are focused on the production of effective rapamycin derivatives to combat the growing demand of this wonder drug. The main focus of the current review is to explore the origin, development, molecular mechanistic action, and the current therapeutic aspects of rapamycin. Also, this review article revealed the potential of rapamycin and the progress of rapamycin research. This helps in understanding the exact potency of the drug and could facilitate further studies that could fill in the existing knowledge gaps. The study also gathers significant data pertaining to the gene clusters and biosynthetic pathways involved in the synthesis and production of this multi-faceted drug. In addition, an insight into the mechanism of action of the drug and important derivatives of rapamycin has been expounded. The fillings of the current review, aids in understanding the underlying molecular mechanism, strain improvement, optimization and production of rapamycin derivatives.

Citing Articles

Sex Disparity in Cancer: Role of Autophagy and Estrogen Receptors.

Vona R, Cittadini C, Ortona E, Matarrese P Cells. 2025; 14(4).

PMID: 39996745 PMC: 11854201. DOI: 10.3390/cells14040273.

Combination of rapamycin and adipose-derived mesenchymal stromal cells enhances therapeutic potential for osteoarthritis.

Veret D, Tejedor G, Perez E, Chomette A, Farno M, Ferreira-Lopez R Stem Cell Res Ther. 2025; 16(1):9.

PMID: 39815291 PMC: 11737215. DOI: 10.1186/s13287-024-04090-8.

Exploring the interactions of rapamycin with target receptors in A549 cancer cells: insights from molecular docking analysis.

Ganesh S, Subathra Devi C J Cancer Res Clin Oncol. 2025; 151(1):31.

PMID: 39762538 PMC: 11703896. DOI: 10.1007/s00432-024-06072-y.

The Neuroprotective Effects of Caffeine in a Neonatal Hypoxia-Ischemia Model are Regulated through the AMPK/mTOR Pathway.

Bernis M, Burkard H, Bremer A, Grzelak K, Zweyer M, Maes E Int J Biol Sci. 2025; 21(1):251-270.

PMID: 39744433 PMC: 11667826. DOI: 10.7150/ijbs.101087.

Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials.

Chatterjee A, Khan R, Mukherjee T, Sahoo P, Tiwari L, Singh B Arch Microbiol. 2024; 206(11):449.

PMID: 39472338 DOI: 10.1007/s00203-024-04179-x.

References

Sadhasivam S, Shanmugam P, Veerapandian M, Subbiah R, Yun K . Biogenic synthesis of multidimensional gold nanoparticles assisted by Streptomyces hygroscopicus and its electrochemical and antibacterial properties. Biometals. 2011; 25(2):351-60. DOI: 10.1007/s10534-011-9506-6. View

Hara O, Murakami T, Imai S, Anzai H, Itoh R, Kumada Y . The bialaphos biosynthetic genes of Streptomyces viridochromogenes: cloning, heterospecific expression, and comparison with the genes of Streptomyces hygroscopicus. J Gen Microbiol. 1991; 137(2):351-9. DOI: 10.1099/00221287-137-2-351. View

Yoo Y, Kim H, Park S, Yoon Y . An overview of rapamycin: from discovery to future perspectives. J Ind Microbiol Biotechnol. 2016; 44(4-5):537-553. DOI: 10.1007/s10295-016-1834-7. View

Chueh S, Kahan B . Clinical application of sirolimus in renal transplantation: an update. Transpl Int. 2005; 18(3):261-77. DOI: 10.1111/j.1432-2277.2004.00039.x. View

Dang L, Liu J, Wang C, Liu H, Wen J . Enhancement of rapamycin production by metabolic engineering in Streptomyces hygroscopicus based on genome-scale metabolic model. J Ind Microbiol Biotechnol. 2016; 44(2):259-270. DOI: 10.1007/s10295-016-1880-1. View

Patsenker E, Schneider V, Ledermann M, Saegesser H, Dorn C, Hellerbrand C . Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepatol. 2010; 55(2):388-98. DOI: 10.1016/j.jhep.2010.10.044. View

Xu Z, Shen W, Chen X, Lin J, Cen P . A high-throughput method for screening of rapamycin-producing strains of Streptomyces hygroscopicus by cultivation in 96-well microtiter plates. Biotechnol Lett. 2005; 27(15):1135-40. DOI: 10.1007/s10529-005-8463-y. View

Fruman D, Wood M, Gjertson C, Katz H, Burakoff S, Bierer B . FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. Eur J Immunol. 1995; 25(2):563-71. DOI: 10.1002/eji.1830250239. View

Kunz J, Hall M . Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. Trends Biochem Sci. 1993; 18(9):334-8. DOI: 10.1016/0968-0004(93)90069-y. View

10.

Prapagdee B, Kuekulvong C, Mongkolsuk S . Antifungal potential of extracellular metabolites produced by Streptomyces hygroscopicus against phytopathogenic fungi. Int J Biol Sci. 2008; 4(5):330-7. PMC: 2556053. DOI: 10.7150/ijbs.4.330. View

11.

Lima S, Melo J, Militao G, Lima G, Lima M, Aguiar J . Characterization of the biochemical, physiological, and medicinal properties of Streptomyces hygroscopicus ACTMS-9H isolated from the Amazon (Brazil). Appl Microbiol Biotechnol. 2016; 101(2):711-723. DOI: 10.1007/s00253-016-7886-9. View

12.

Cai P, Kong F, Ruppen M, Glasier G, Carter G . Hygrocins a and B, naphthoquinone macrolides from Streptomyces hygroscopicus. J Nat Prod. 2005; 68(12):1736-42. DOI: 10.1021/np050272l. View

13.

Heisey R, Putnam A . Herbicidal effects of geldanamycin and nigericin, antibiotics from Streptomyces hygroscopicus. J Nat Prod. 1986; 49(5):859-65. DOI: 10.1021/np50047a016. View

14.

Singh M, Petersen P, Weiss W, Janso J, Luckman S, Lenoy E . Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. Antimicrob Agents Chemother. 2002; 47(1):62-9. PMC: 148986. DOI: 10.1128/AAC.47.1.62-69.2003. View

15.

Johnson L, Dietz A . Scopafungin, a crystalline antibiotic produced by Streptomyces hygroscopicus var. enhygrus var. nova. Appl Microbiol. 1971; 22(3):303-8. PMC: 376304. DOI: 10.1128/am.22.3.303-308.1971. View

16.

Gesheva V . Optimization of the production medium for biosynthesis of antifungal antibiotic AK-111-81 by phosphate-deregulated mutant of Streptomyces hygroscopicus. Appl Biochem Biotechnol. 2009; 158(1):20-4. DOI: 10.1007/s12010-009-8629-5. View

17.

Uyeda M, Mizukami M, Yokomizo K, Suzuki K . Pentalenolactone I and hygromycin A, immunosuppressants produced by Streptomyces filipinensis and Streptomyces hygroscopicus. Biosci Biotechnol Biochem. 2001; 65(5):1252-4. DOI: 10.1271/bbb.65.1252. View

18.

Palaniappan N, Ayers S, Gupta S, Habib E, Reynolds K . Production of hygromycin A analogs in Streptomyces hygroscopicus NRRL 2388 through identification and manipulation of the biosynthetic gene cluster. Chem Biol. 2006; 13(7):753-64. DOI: 10.1016/j.chembiol.2006.05.013. View

19.

Lee S, Choe H, Bae K, Park D, Nasir A, Kim K . Complete genome of Streptomyces hygroscopicus subsp. limoneus KCTC 1717 (=KCCM 11405), a soil bacterium producing validamycin and diverse secondary metabolites. J Biotechnol. 2015; 219:1-2. DOI: 10.1016/j.jbiotec.2015.12.010. View

20.

Volff J, Altenbuchner J . Genetic instability of the Streptomyces chromosome. Mol Microbiol. 1998; 27(2):239-46. DOI: 10.1046/j.1365-2958.1998.00652.x. View